About the Company
We do not have any company description for Ikena Oncology, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $IKNA News
Ikena Oncology, Inc.
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline ...
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
A downtrend has been apparent in Ikena Oncology, Inc. (IKNA) lately with too much selling pressure. The stock has declined 29.1% over the past four weeks. However, given the fact that it is now in ...
Ikena Oncology Inc (IKNA) Stock: A Look at the Analyst Recommendations
Based on Ikena Oncology Inc (IKNA), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -7.43. The debt to equity ratio ...
The -13.88% Decline of Ikena Oncology Inc’s (IKNA) Stock in the Past Quarter
IKNA stock has gone up by 1.47%, with a monthly decline of -0.72% and a quarterly plunge of -31.00%. The volatility ratio for the week is 9.46%, and the volatility levels for the last 30 days are 7.86 ...
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
BOSTON, April 10, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment ...
Ikena Oncology gets grant for cancer treatment method using compounds of formula i
Discover the groundbreaking patent by Ikena Oncology Inc for treating cancer with specific compounds and methods. Learn how this innovative approach targets cancers with increased TEAD expression, ...
The Analyst Landscape: 4 Takes On Ikena Oncology
Stay informed and make well-judged decisions with the assistance of our Ratings Table. Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that ...
Ikena Oncology Inc IKNA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ikena Oncology Inc (IKNA)
Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today ...
Ikena Oncology Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
IKNA Ikena Oncology, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Loading the latest forecasts...